Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2014-15
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2014-15
1. Annual Report
Torrent Do Brasil Ltda
Zao Torrent Pharma
Torrent Pharma S.R.L
Torrent Pharma Inc
Torrent Pharma GmbH
Torrent Pharma France S.A.S.
Torrent Pharma Canada Inc
Torrent Pharma (UK) Ltd
Torrent Pharma (Thailand) Co., Limited
Torrent Australasia Pty Ltd
Norispharm GmbH
Laboratorios Torrent, S.A. de C.V
Laboratorios Torrent (Malaysia) SDN.BHD
Heunet Pharma GmbH
Heumann Pharma GmbH & Co. Generica KG
Aptil Pharma Limited
Annual Report
2. Intimation to Stock Exchange
Torrent enters into exclusive licensing agreement with Reliance Life Sciences for 3 biosimilars
Shareholding Pattern Q4
Shareholding Pattern Q3
Shareholding Pattern Q2
Shareholding Pattern Q1
Quarterly Compliance Report Q3
Quarterly Compliance Report Q2
Quarterly Compliance Report Q1
Notice u_s 160 of Companies Act, 2013
Notice of Book Closure for Dividend on Equity Shares
Newspaper Notice of AGM and E-voting Procedure
Notice of 42nd AGM
3. Postal Ballot & E-voting
42nd AGM-Chairman Result and Scrutiniser Report
Result of Postal Ballot Dated 12th March, 2015
Postal Ballot notice & form
Postal Ballot form
4. Quarterly Results
Q1 14-15
Q2 14-15
Q3 14-15
Q4 14-15
Press Release on Q1 Results
Investors Presentation
Q1, FY 2015Con call Transcript
Consolidated Results
Stand Alone Results
Investors Presentation
Investors Presentation : TELECONFERENCE
Press Release on Q2 Results
Investors Presentation
Q2, FY 2015 Con call Transcript
Consolidated Results
Stand Alone Results
Investors Presentation
Investors Presentation : TELECONFERENCE
Press Release on Q3 Results
Investors Presentation
Investors Presentation
Q3, FY 2015 Con call Transcript
Consolidated Results
Stand Alone Results
Investors Presentation : TELECONFERENCE
Investors Presentation
Press Release on Q4 Results
Investors Presentation
Investors Presentation
Q4, FY 2015 Con call Transcript
Consolidated Results
Stand Alone Results
Investors Presentation : TELECONFERENCE
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>
